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Aspects of Experimental Hepatocarcinogenesis
PART Ill. IRON OVERLOAD AND HEPATOCARCINOGENESIS
A. H. TIMME
SUMMARY
In order to investigate the possible influence of iron
overload in the live"r on the carc:nogenic action of p-
dimethylam;noazobenzene (P-DAB), a group of 40 ra:s
was fed 4 % ferric citrate in maize until the livers became
quite markedly siderotic. p-DAB was then fed to the
animals. No difference was observed between the experi-
mental and con:rol groups with regard to the final number
of liver tumours which were produced. In the siderotic
animals the fibrous tissue septa were occasionally broader
than is usually the case in the controls and a prominent
bile ductal response was sometimes evoked. It is con-
cluded that iron overload does not significantly influence
the action of a fairly potent carcinogen such as p-DAB.
S. Afr. Med. l., 48, 1293 (1974).
In haemochromatosis the incidence of primary carcinoma
of the liver is said to range from 11,5% to 42,9%,'" while
in non-pigmentary cirrhosis the incidence is usually accept-
ed as being much lower.' The reason for the high rate of
malignant degeneration in haemochromatosis is not clear,
though the iron itself may obviously be a factor. In
contrast to this, the belief is generally held that in the
indigenous Black races of South Africa iron is not an
important factor in the development of primary liver
carcinoma. ,·s While there is no evidence to refute this
hypothesis, the possibility that iron excess may aid the
induction of tumours by other carcinogenic agents cannot
as yet be completely excluded, especially in view of the
known association of carcinoma and haemochromatos:s.
It has previously been shown" that iron overload may be
a decisive factor in determining the effects of a weak
hepatotoxic agent, e.g. acetamide. In these experiments
the acetamide (a known carcinogen in some strains of rats)
was able to elicit the formation of small, tumour-like
nodules only in the presence of hepatic siderosis, while
in the absence of excess liver iron it proved to be relatively
innocuous even when administered for prolonged periods.
In order, therefore, to explore the effects of iron overload
on the actiori of a more powerful carcinogen, p-
dimethylaminoazobenzene (p-DAB) was employed. This
is known to be able to consistently produce a high inci-
dence of liver cancer in the local strain of rats.
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EXPERIMENTAL METHOD
A group of 50 male rats of a locally bred albino strain
was used. The weight of each animal at the onset of the
experiment was 100 g. The animals were initially fed a
maize diet to which ferric citrate had been added in a
proportion of 4 % by weight. This feeding continued for
2 months. A number of biopsies were done at this time and
confirmed that the livers were siderotic. Ferric citrate
administration was then stopped, and p-DAB feeding com-
menced, 0,05 % (w I w) of the dye being mixed with the
maize. Five animals were sacrificed at monthly intervals
for the first 4 months after the start of the carcinogen diet.
The remaining 30 animals remained on the carcinogen
diet for a total of 20 weeks, after which they remained
on a maize diet until the end of the experiment at 40
weeks.
When the animals died or were killed, a full autopsy was
done. Tissue was removed from 2 or 3 lobes of the "liver
and processed for histological study by conventional
methods. Sections were stained with haematoxylin and
eosin, Perls' stain for iron, and with collagen and reticulin
stains.
Since this experiment was undertaken at the same time
as an investigation on a much larger series of 100 rats, in
which the rats were killed at weekly intervals, it was
considered that the latter would adequately serve as con-
trols for the present experiment. The dosage of carcinogen
and the basic maize diet were identical in the two groups.
RESULTS
Experimental Animals
By the end of the experiment at 40 weeks, 20 of the
30 animals had developed liver tumours (70 %). These
included liver cell carcinomas of trabecular type, llIldif-
ferentiated solid carcinomas and adenocarcinomas, some
of which were mixed tumours. The distribution of these
three main tumour types were similar to that normally
produced by using the present experimental methods (40 %,
40%, 20%). The cirrhosis which accompanied all the
tumours resembled that produced under 'iron-free' or con-
trol conditions, except that in about a quarter of the
animals the fibrous tissue septa tended to be wider and bile
duct proliferation was often more conspicuous (Fig. I).
The parenchymal cell changes, both degenerative and
regenerative, were virtually identical in the two groups.
By the end of the experiment the liver cells were almost
totally iron-free; most of the iron present was contained
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in large iron-laden macrophages 10 tbe fibrous tissue
septa.
During the first 3 - 4 months of carcinogen administra-
tion, when the liver cells still contained iron in tbe cyto-
plasm, there was usually little quantitative or qualitative
difference in the response of the iron-laden liver when
compared with the controls.
Fig. 1. A cirrhotic nodule (upper left) is surrounded by a
large mass of proliferated bile ducts. Many iron-laden
macrophages are present (arrows) (H. and E. X 500).
Controls
Of 40 animals which survived until the end of the experi-
ment, 28 developed liver tumours (70%).
DISCUSSION
The possible role of excess iron in the production of liver
disease is still controversial. It was demonstrated by
Witzleben and Chaffei' that in the iron-laden liver the
level of glucose-6-phospl.J.atase actually was reduced com-
pared with controls and, moreover, certain hepatotoxins,
e.g. bromobenzene, could produce a greater fall in enzymes
in such livers when compared with controls. 'There is also
evidence to .suggest that while massive iron overload in
the liver per se does not lead to any gross degree of hepatic
damage," the combination of excess iron and an additional
toxin, e.g. ethionine, may result in an increase in the
severity and rapidity of development of cirrhotic changes
in the livers of rats. '2 However, these findings have also
been challenged. l3 It may be noted, too, that Bantu siderosis
can be associated with hepatic fibrosis and. on occasions a
cirrhosis of portal type. H Though the position is therefore
far from clear, it does seem that excess iron is not entirely
innocuous. Its effects may depend on highly specific cir-
cumstances which still remain to be accurately defined,
an opinion which has already been voiced. "
With this background, and in view of the high incidence
of hepatic siderosis in the Black races of South Africa and
the known association of primary liver cancer and haemo-
chromatosis, the problem of the possible ancillary role
of iron in the pathogenesis of malignant disease seemed
worth re-examining.
In order to investigate this problem, Dunn" fed rats
ethionine and gave them iron-dextran injections. Although
the livers developed siderosis, no increase in the numbers
of liver tumours was observed. In experiments performed
by Williams and Yamamoto,16 siderosis was induced in
rats by the feeding of 8-hydroxyquinoline (HQ) with or
without added ferrous gluconate, and the animals were
then fed various carcinogens. In those animals fed the
carcinogen plus HQ the' incidence of liver cancer was
lower than in those animals fed the carcinogen only.
Experiments such as these are confusing, however, since
the HQ could be antagonistic to the carcinogens.
The present studies have now shown that prior iron
overload has failed to influence the carcinogenic effects
of p-DAB. There was no difference in the percentage of
animals which ultimately developed liver cancers or in
the stage at which they appeared when these were com-
pared with the controls. It should be noted that for most
of the period during which the carcinogen was fed
(20 weeks), iron was actually present in the liver cells,
though in decreasing amouI!ts. At the end of the experi-
ment the liver cells contained little or no stainable iron.
In the present experiments some increased collagen and
reticulin formation did occur, but this was not surprising
since it has been postulated that iron may stimulate
fibrogenesis. '< Differences between the effects of p-DAB
and ethionine in this regard may be due to dietary or
other influences, e.g. the strain of animals used.
In an earlier study it was reported that iron overload
could apparently enhance the action of a weak carcinogen,
acetamide, provided the iron was given in large doses at
tbe same time as the carcinogen: This potentiating effect
of iron is not demonstrable when more powerful carcino-
gens are used. The findings may therefore shed some light
on the fact that Bantu siderosis is not of special signifi'-
cance in tumour formation. Any possible enhancing in-
fluence which iron could exert would simply not be detect-
able in a population group in which there is already a high
incidence of the disease, and which is presumably exposed
to powerful carcinogenic influences, e.g. aflatoxin.
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